Lumida
/SNDX
⌘K
Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc

SNDX
$18.18USD-3.40%-0.64 today

MARKET CAP

1.6B

P/E (TTM)

FWD P/E

DAY RANGE

$18 – $19

52W RANGE

$13
$26

AI Summary

Stalk
Sell NowMedium

The stock failed its key support cluster near earlier lows and now trades below all major EMAs, signaling a breakdown rather than a pullback. The medium-term structure is bearish with further downside likely as supply overwhelms demand, and short-term price momentum confirms unfavorable timing. We are selling now into the continued decline, targeting participation in the accelerating down move.

  • Revuforj and Niktimvo generate ~$200M annually, validating commercial viability
  • Upcoming clinical data readouts could act as major growth catalysts
  • Profit margins are deeply negative and earnings yield remains below zero
Full analysis →

Buying

6

institutions

Selling

8

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY9.02 M197.18 M+765.58 K+2.3%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL2.80 M61.17 M+-87.41 K-9.3%3.17%
MM

Millennium Management LLC

Q2 2026

BUY2.05 M44.90 M+1.85 M+863.3%0.02%
WP

Woodline Partners LP

Q2 2026

SELL1.25 M27.34 M+-1.25 M-53.2%0.08%
AC

Aqr Capital Management LLC

Q2 2026

SELL853.30 K18.65 M+-127.01 K-18.6%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL344.88 K7.54 M+-422.66 K-58.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL321.60 K7.03 M+-176.60 K-39.6%0.01%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY309.06 K6.76 M+104.22 K+41.2%0.05%
JC

Jpmorgan Chase & Co

Q2 2026

SELL231.45 K5.13 M+-27.07 K-11.8%0.00%
MG

Man Group Plc

Q2 2026

BUY213.70 K4.67 M+31.69 K+9.9%0.01%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW84.00 K1.84 M+84.00 K+0.0%0.42%
JH

Janus Henderson Group Plc

Q1 2026

BUY78.67 K1.84 M+39.34 K+122.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-1.99 M-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-17.50 K-100.0%0.00%